Study details cancer risk of Takeda diabetes pill

LONDON, May 31 (Reuters) - Taking Takeda Pharmaceutical's diabetes drug Actos for more than two years doubles the risk of bladder cancer, although in absolute terms the risk is still low, researchers…
Read the full story: Reuters: Healthcare